Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-111016%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.76 - $ 10.48 52-Week Range
Ticker Information
Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMUNE BIO INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INMB - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -55.51M | -111016% | $ 50K |
| 3/31/2025 | $ -40.8M | -81592% | $ 50K |
| 12/31/2024 | $ -42.08M | -300585.71% | $ 14K |
| 9/30/2024 | $ -41.27M | -98266.67% | $ 42K |
| 6/30/2024 | $ -37.74M | -44402.35% | $ 85K |
| 3/31/2024 | $ -34.5M | -26333.59% | $ 131K |
| 12/31/2023 | $ -30.01M | -19360% | $ 155K |
| 9/30/2023 | $ -27.43M | -12246.87% | $ 224K |
| 6/30/2023 | $ -26.59M | -9532.26% | $ 279K |
| 3/31/2023 | $ -26.93M | -10816.06% | $ 249K |
Key Performance Insights, Last 5 Years
- INMUNE BIO INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, INMUNE BIO INC's average EBITDA % has been -67350.77%.
- The median EBITDA % for INMUNE BIO INC during this period was -26333.59%
- INMUNE BIO INC reached its highest EBITDA % over the past 5 years at -7076.59%.
- The lowest EBITDA % recorded by INMUNE BIO INC in the same timeframe -300585.71%
INMUNE BIO INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for INMUNE BIO INC is calculated as follows: EBITDA [ $ -11.21M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] INMB - EBITDA Margin, Last 5 years
-300585.71%
Minimum
Dec 31, 2024
-7076.59%
Maximum
Sep 30, 2022
-67350.77%
Average
-26333.59%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |